October Cyto-econference 2018
Oct 23 @ 3:00 pm – 4:00 pm
Interpretation of FNA Material of Lymph Nodes Involved by Lymphoproliferative Disorders

Marino Leon, MD

Selected common and challenging lymphoproliferative disorders involving lymph nodes and encountered in a current cytopathology practice, will be reviewed in this session. Common pitfalls in the diagnostic assessment of these neoplasms will be reviewed integrating clinical presentation, imaging findings, and ancillary testing. The role of the cytopathologist and cytotechnologist in the multidisciplinary team will also be highlighted.

Earn 2 credits per webinar

66th Annual Scientific Meeting
Nov 10 – Nov 13 all-day
The American Society of Cytopathology is currently welcoming proposal submissions for presentations during the 66th Annual Scientific Meeting taking place in Washington, DC, November 10-13, 2018.

This year’s educational objectives include:

  • The integration of recent advances in cytopathology with current practice
  • The demonstration of the role of research in expanding the field of cytopathology and optimizing patient care
  • The identification of current best practices in cytopathology and cytotechnology educaiton
  • The creation of a forum for advocacy on behalf of cytopathologists, cytotechnologists, and their patients

Learn more at cytopathologymeeting.org.

November Cyto-econference 2018
Nov 27 @ 3:00 pm – 4:00 pm

Non-small Cell Carcinoma Biomarker Testing: The Cytopathologist’s Viewpoint

Abberly Lott Limbach, MD

Many decisions about treatment in lung cancer are made on the basis of specific molecular and protein expression. This webinar is designed to give practicing cytopathologists a general introduction to the targeted therapy testing required for non-small cell lung carcinomas as well as a strategy to maximize limited specimens for several rounds of testing. In this course we will review the pre-analytical factors in specimen collection, from EBUS to biopsy to resection, and consider how specimen collection can affect testing. Finally, we will discuss several case examples alongside the targeted therapy testing followup and consider how to integrate targeted therapy testing into the cytopathologist’s immediate assessment workflow.

Earn 2 credits per webinar

December Cyto-econference 2018
Dec 11 @ 3:00 pm – 4:00 pm

Discrepancies and Errors in Cytology Cases with Emphasis on Recognizing the Sources of Errors

Farnaz Hasteh, MD

This webinar with provide a practical review of a few litigation or mis- diagnosed cytology cases that were identified after correlation with the surgical outcomes. Using case-based presentation; this webinar will present challenging gynecological and non-gynecologic cases. The goal of this webinar will be to increase the skills of cytopatholgists and surgical pathologists to recognize potential diagnostic pitfalls in diagnosis. Erroneous diagnosis can cause delay in diagnosis or sometimes overtreatment and unnecessary surgeries. Our goal is to learn from these mistakes and improve our abilities to prevent future ones. Solutions for handling similar cases with the listing of differential diagnosis, clear cytopathology reporting and finally assessment of surgical outcomes will be provided.

Earn 2 credits per webinar

January Cyto-econference 2019
Jan 22 @ 3:00 pm – 4:00 pm

The Paris System for Reporting Urine Cytology – The WHY, HOW and WHAT to Watch Out For

Shikha Bose, MD

Urine cytology, with cystoscopic examination, remains the standard of practise in the initial evaluation of lower urinary tract lesions to rule out bladder cancer. However, cystoscopy is invasive and may miss some flat lesions, whereas cytology is not very useful in the detection of low-grade papillary neoplasms. Thus, The Paris System for Reporting Urinary Cytology has been developed by members of the American Society of Cytopathology and the International Academy of Cytology to standardize the reporting of urine cytology cases with the goal of improving the detection of high grade urothelial carcinoma. Morphologic criteria for the diagnosis of urothelial carcinoma and intermediate categories of atypia have been better defined. The criteria for each of the categories are based on the best available clinical outcomes evidence. The webinar will address the morphologic features of the different diagnostic categories using case based examples and will identify the potential pitfalls.

Earn 2 credits per webinar